EUVIMEDEUVIMED entdecken
Open Access

IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells

Min Wu, Lin Zhang, Lifu Pi, Layang Liu, Siyu Wang, Yujie Wu, Hongli Pan, Mingyao Liu, Zhengfang Yi

Cellular Oncology · 2024

DOI: 10.1007/s13402-024-00961-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Min Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dong C…. Hauptthemen laut MEDLINE: Paclitaxel, Triple Negative Breast Neoplasms, Protein Serine-Threonine Kinases, Endoribonucleases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, The Science and Technology Commission of Shanghai Municipality, ECNU Construction Fund of Innovation and Entrepreneurship Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelTriple Negative Breast NeoplasmsProtein Serine-Threonine KinasesEndoribonucleasesDrug Resistance, NeoplasmHumansCell Line, TumorFemaleAnimalsXenograft Model Antitumor AssaysX-Box Binding Protein 1MiceMice, NudeUnfolded Protein ResponseDrug SynergismSignal TransductionMice, Inbred BALB CCell Proliferation

Stichwörter der Autor:innen

Drug combinationIRE1αPaclitaxelTNBC

Substanzen

PaclitaxelProtein Serine-Threonine KinasesEndoribonucleasesERN1 protein, humanX-Box Binding Protein 1XBP1 protein, human

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dong Chuan Rd, Shanghai, 200241, China.
  • Shanghai World Foreign Language Academy, Shanghai, 200030, China.
  • Department of Reproductive Medicine, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, 272000, China.
  • Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dong Chuan Rd, Shanghai, 200241, China. zfyi@bio.ecnu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • The Science and Technology Commission of Shanghai Municipality
  • ECNU Construction Fund of Innovation and Entrepreneurship Laboratory
  • Shanghai Rising-Star Program

Zitieren

APA

Wu, M., Zhang, L., Pi, L., Liu, L., Wang, S., Wu, Y., Pan, H., Liu, M., & Yi, Z. (2024). IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells. Cellular Oncology. https://doi.org/10.1007/s13402-024-00961-7

Vancouver

Wu M, Zhang L, Pi L, Liu L, Wang S, Wu Y, et al. IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells. Cellular Oncology. 2024. doi:10.1007/s13402-024-00961-7

BibTeX
@article{Wu2024,
  author = {Wu, Min and Zhang, Lin and Pi, Lifu and Liu, Layang and Wang, Siyu and Wu, Yujie and Pan, Hongli and Liu, Mingyao and Yi, Zhengfang},
  title = {IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells},
  journal = {Cellular Oncology},
  year = {2024},
  doi = {10.1007/s13402-024-00961-7}
}
Kostenlos starten →